Article metrics
PDF
Other content recommended for you
- Neurology and the liver
- Hepatic encephalopathy due to liver cirrhosis
- Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials
- Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)
- Hepatic encephalopathy: a neurologist’s perspective
- Management of hepatic encephalopathy in children
- Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis
- Unexpected clinical outcomes following the implementation of a standardised order set for hepatic encephalopathy
- Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy: a multicentre, observer blinded, validation study
- Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates